Scott M. Galovan serves as Executive Vice President and Chief Financial Officer of Avanos Medical, Inc., a global medical technology company specializing in innovative solutions for pain management, acute care, and respiratory and digestive health. In this role, he leads the company's worldwide finance organization, encompassing accounting, financial planning and analysis, tax, treasury, investor relations, information technology, and corporate development. Galovan's strategic oversight drives financial discipline, supports business growth, and positions Avanos to deliver long-term value to shareholders while advancing patient-centered innovations. With more than 25 years of progressive finance leadership in healthcare and consumer products, Galovan joined Avanos in 2021 following its spin-off from Halyard Health. He previously served as Senior Vice President and CFO at Halyard Health, where he orchestrated the company's 2014 separation from Kimberly-Clark Corporation and navigated key strategic milestones. Earlier in his career, Galovan held senior finance roles at Kimberly-Clark, including Vice President of Finance for North America Acute Care, and began his professional journey in various capacities at GE Capital Real Estate. Galovan's achievements include spearheading complex transactions such as mergers, acquisitions, and divestitures, optimizing capital structures, and enhancing operational efficiencies across multibillion-dollar organizations. A certified public accountant and holder of an MBA from the University of Georgia, he has been instrumental in strengthening Avanos's financial foundation, enabling investments in R&D and global expansion while fostering a culture of accountability and innovation.